NEWS
Craig Marks has been appointed by Sandoz, the Swiss pharmaceutical company, as Head of Investor Relations
Craig Marks has recently started a new role as Head of Investor Relations at the Swiss pharmaceutical company, Sandoz. Prior to this, Marks served as Vice President, Investor Relations at Ipsen and was Head of Investor Relations at AstraZeneca. Marks has also worked in senior Investor Relations and Corporate Communications roles at Halfords and Britvic.